Yorktown Management & Research Company’s Gilead Sciences GILD Stock Holding History

Yorktown Management & Research Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-70,000	Closed	-$4.38M	–	326
2018 Q4	$4.38M	Hold	70,000	–	–	1.45%	10
2018 Q3	$5.41M	Buy	70,000 +30,000	+75%	+$2.27M	1.58%	8
2018 Q2	$2.83M	Hold	40,000	–	–	0.82%	23
2018 Q1	$3.02M	Buy	40,000 +19,000	+90%	+$1.51M	0.89%	20
2017 Q4	$1.5M	Buy	+21,000	New	+$1.59M	0.43%	53
2014 Q2	–	Sell	-3,600	Closed	-$255K	–	491
2014 Q1	$255K	Hold	3,600	–	–	0.05%	300
2013 Q4	$271K	Hold	3,600	–	–	0.05%	252
2013 Q3	$226K	Buy	+3,600	New	+$215K	0.05%	284

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Yorktown Management & Research Company's GILD Position: Q1 2019 in Review

Yorktown Management & Research Company sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 70,000 shares — an estimated $4.38M sold.

Yorktown Management & Research Company first reported a position in GILD in Q3 2013 and held it in 8 quarters. The position peaked at $5.41M in Q3 2018. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

Yorktown Management & Research Company reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
Yorktown Management & Research Company sold 70,000 Gilead Sciences shares in Q1 2019, an estimated $4.38M.
Yorktown Management & Research Company first reported a position in Gilead Sciences in Q3 2013 and held it in 8 quarters.
Yorktown Management & Research Company's Gilead Sciences position peaked at $5.41M in Q3 2018.
1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Yorktown Management & Research Company's 13F filing for Q1 2019, filed 13 May 2019.